About the role

Performance Marketing Lead

At Wyndly, we're fixing allergies for 100 million Americans by training their bodies to ignore allergy triggers. We've built a successful B2B channel, and now we're looking for someone obsessed with cracking direct-to-consumer acquisition to unlock our next phase of growth.

The Role

We need a hands-on performance marketer who can figure out why doctors can sell our treatment but Facebook ads can't. You'll own all paid acquisition channels, turn customer insights into profitable campaigns, and build the playbook.

What You'll Actually Be Doing

Own paid acquisition end-to-end : Meta, Google, TikTok - you'll manage budgets, write copy, brief creatives, and optimize daily
Crack our positioning puzzle : Interview customers, identify why they buy, and test messaging until CAC makes sense against our LTV
Turn our organic momentum into paid growth : We get 1M+ views monthly on TikTok/YouTube, and you'll turn that into paid insights
Build the testing machine : Launch experiments weekly across ads, landing pages, and offers
Partner with creative resources : You won't design, but you'll know exactly what creative to brief based on performance data
Work within our existing stack : Shopify & Klaviyo

Who You Are

Performance marketer with 3-5 years experience scaling D2C brands, ideally in health/wellness
Analytical but not paralyzed : Comfortable with CAC/LTV math, cohort analysis, and quick decision-making from incomplete data
Writer first, media buyer second : Your copy clarity matters more than your Facebook Ads Manager expertise
Scrappy experimenter : You've grown something from nothing before, even if it was your failed dropshipping store
Naturally curious : You're already wondering why our B2B works but D2C doesn't, and you have hypotheses
Bonus points : You have allergies and personally understand why people suffer through symptoms rather than seek treatment

Why This Role Matters

Every day, thousands of allergy sufferers search for relief but don't know they can be cured. You'll be the bridge between their suffering and our solution. This isn't about arbitraging CAC/LTV - it's about cracking the code on how to communicate life-changing treatment to people who've given up hope.

Compensation & Growth

$140,000-$180,000 all-in compensation
Over 1% equity - real ownership in the outcome you create

Getting Started

If you're excited to learn more, fill out the form on this page. If we think you might be a fit, we'll respond within 48 hours. Please let us know if you have timing constraints. Regardless, we'll try our best to respect your time along the process.

Note: We know the best growth marketers don't always have perfect resumes. If you're obsessed with solving our problem but don't check every box, apply anyway and tell us why you're the one.

About Wyndly

What is Wyndly?

Wyndly (YC W21) fixes allergies by training patients' bodies to ignore their allergy triggers. Frustrated allergy suffers come to us when they no longer want to deal with pills and sprays. We diagnose the patient’s unique allergy profile and create a personalized treatment plan to give the patient lifelong allergy relief. Specifically, Wyndly is increasing access to sublingual immunotherapy (SLIT) for allergy care. For our patients, we're combining the convenience of telehealth and direct-to-consumer care with an exceptional patient experience that never loses the context of care.

Wyndly represents an opportunity to change allergy care forever. With 60 million Americans suffering from allergies today, and with this number doubling over the coming years, there's simply an incredible need for the convenient care Wyndly provides.

You can read more about us in Techcrunch.

The Wyndly Model

At Wyndly, we believe that better connections lead to better care, and we’re committed to making both happen at every step of the patient journey. Our allergy practice allows our patients to work with expert providers to develop personalized treatment plans for long-term allergy relief using clinically proven therapies. From a patient’s initial consultation to their final treatment delivery, we want the Wyndly experience to be a breath of fresh air for allergy sufferers – truly effective allergy relief, simply and efficiently delivered.

Once we've conquered allergies, we're transforming the care model for every chronic condition. While transactional care for purchasing pills has flourished in telehealth, no one has gone after chronic care. Patients with chronic conditions are shuffled between providers, insurance, and more -- and they never feel heard. These patients deserve better, and we're going to give it to them. Wyndly is starting with allergies, but we'll expand into asthma, sleep apnea, and other conditions in the near future.

Our values

Compassion: We approach all our patients and partners with an open mind and a genuine desire to be of service.

Focus: We do a few things very well, and are always clear about our boundaries and direction of travel.

Courage: We embrace ambiguity and discomfort because we know that’s how we grow.

Progress: We make something better every single day.

It boils down to empathy and forward momentum in everything we do.

The team

Wyndly is proudly backed by Y Combinator and a leading group of angel investors and VCs. The founders are Dr. Manan Shah (Chief Medical Officer), an ear-nose-and-throat surgeon who’s a leading practitioner of telehealth in his specialty, and his cousin Aakash Shah (CEO), who led growth engineering at SparkGift (acquired by Stockpile in 2016) and Parse.ly (acquired by Automattic in 2021).